212 related articles for article (PubMed ID: 28053049)
1. Genome-wide association study with additional genetic and post-transcriptional analyses reveals novel regulators of plasma factor XI levels.
Sennblad B; Basu S; Mazur J; Suchon P; Martinez-Perez A; van Hylckama Vlieg A; Truong V; Li Y; Gådin JR; Tang W; Grossman V; de Haan HG; Handin N; Silveira A; Souto JC; Franco-Cereceda A; Morange PE; Gagnon F; Soria JM; Eriksson P; Hamsten A; Maegdefessel L; Rosendaal FR; Wild P; Folsom AR; Trégouët DA; Sabater-Lleal M
Hum Mol Genet; 2017 Feb; 26(3):637-649. PubMed ID: 28053049
[TBL] [Abstract][Full Text] [Related]
2. A genome-wide association study identifies KNG1 as a genetic determinant of plasma factor XI Level and activated partial thromboplastin time.
Sabater-Lleal M; Martinez-Perez A; Buil A; Folkersen L; Souto JC; Bruzelius M; Borrell M; Odeberg J; Silveira A; Eriksson P; Almasy L; Hamsten A; Soria JM
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):2008-16. PubMed ID: 22701019
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing to dissect the genetic architecture of KNG1 and F11 loci using factor XI levels as an intermediate phenotype of thrombosis.
Martin-Fernandez L; Gavidia-Bovadilla G; Corrales I; Brunel H; Ramírez L; López S; Souto JC; Vidal F; Soria JM
PLoS One; 2017; 12(4):e0176301. PubMed ID: 28445521
[TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of activity and antigen levels of contact system factors.
Rohmann JL; de Haan HG; Algra A; Vossen CY; Rosendaal FR; Siegerink B
J Thromb Haemost; 2019 Jan; 17(1):157-168. PubMed ID: 30288888
[TBL] [Abstract][Full Text] [Related]
5. Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.
Tang W; Schwienbacher C; Lopez LM; Ben-Shlomo Y; Oudot-Mellakh T; Johnson AD; Samani NJ; Basu S; Gögele M; Davies G; Lowe GD; Tregouet DA; Tan A; Pankow JS; Tenesa A; Levy D; Volpato CB; Rumley A; Gow AJ; Minelli C; Yarnell JW; Porteous DJ; Starr JM; Gallacher J; Boerwinkle E; Visscher PM; Pramstaller PP; Cushman M; Emilsson V; Plump AS; Matijevic N; Morange PE; Deary IJ; Hicks AA; Folsom AR
Am J Hum Genet; 2012 Jul; 91(1):152-62. PubMed ID: 22703881
[TBL] [Abstract][Full Text] [Related]
6. Common variants of large effect in F12, KNG1, and HRG are associated with activated partial thromboplastin time.
Houlihan LM; Davies G; Tenesa A; Harris SE; Luciano M; Gow AJ; McGhee KA; Liewald DC; Porteous DJ; Starr JM; Lowe GD; Visscher PM; Deary IJ
Am J Hum Genet; 2010 Apr; 86(4):626-31. PubMed ID: 20303064
[TBL] [Abstract][Full Text] [Related]
7. KNG1 Ile581Thr and susceptibility to venous thrombosis.
Morange PE; Oudot-Mellakh T; Cohen W; Germain M; Saut N; Antoni G; Alessi MC; Bertrand M; Dupuy AM; Letenneur L; Lathrop M; Lopez LM; Lambert JC; Emmerich J; Amouyel P; Trégouët DA
Blood; 2011 Mar; 117(13):3692-4. PubMed ID: 21270443
[TBL] [Abstract][Full Text] [Related]
8. A genetic association study of activated partial thromboplastin time in European Americans and African Americans: the ARIC Study.
Weng LC; Cushman M; Pankow JS; Basu S; Boerwinkle E; Folsom AR; Tang W
Hum Mol Genet; 2015 Apr; 24(8):2401-8. PubMed ID: 25552651
[TBL] [Abstract][Full Text] [Related]
9. Regulation of coagulation factor XI expression by microRNAs in the human liver.
Salloum-Asfar S; Teruel-Montoya R; Arroyo AB; García-Barberá N; Chaudhry A; Schuetz E; Luengo-Gil G; Vicente V; González-Conejero R; Martínez C
PLoS One; 2014; 9(11):e111713. PubMed ID: 25379760
[TBL] [Abstract][Full Text] [Related]
10. The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis.
Lunghi B; Cini M; Legnani C; Bernardi F; Marchetti G
Thromb Res; 2012 Sep; 130(3):563-4. PubMed ID: 22633531
[No Abstract] [Full Text] [Related]
11. Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis.
Zhong C; Zhang L; Chen L; Deng L; Li R
J Thromb Haemost; 2017 Jan; 15(1):122-130. PubMed ID: 27813324
[TBL] [Abstract][Full Text] [Related]
12. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX.
Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871
[TBL] [Abstract][Full Text] [Related]
13. Factor 11 single-nucleotide variants in women with heavy menstrual bleeding.
Wiewel-Verschueren S; Mulder AB; Meijer K; Mulder R
J Obstet Gynaecol; 2017 Oct; 37(7):912-918. PubMed ID: 28609141
[TBL] [Abstract][Full Text] [Related]
14. Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XI.
Georgi B; Mielke J; Chaffin M; Khera AV; Gelis L; Mundl H; van Giezen JJJ; Ellinor P; Kathiresan S; Ziegelbauer K; Freitag DF
Stroke; 2019 Nov; 50(11):3004-3012. PubMed ID: 31558144
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism-related genetic determinant F11 rs4253417 is a potential prognostic factor in ischaemic stroke.
Tavares V; Assis J; Pinto R; Freitas-Silva M; Medeiros R
Mol Cell Probes; 2023 Aug; 70():101917. PubMed ID: 37364690
[TBL] [Abstract][Full Text] [Related]
16. Factor XI: hemostasis, thrombosis, and antithrombosis.
He R; Chen D; He S
Thromb Res; 2012 May; 129(5):541-50. PubMed ID: 22197449
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis.
Hinds DA; Buil A; Ziemek D; Martinez-Perez A; Malik R; Folkersen L; Germain M; Mälarstig A; Brown A; Soria JM; Dichgans M; Bing N; Franco-Cereceda A; Souto JC; Dermitzakis ET; Hamsten A; Worrall BB; Tung JY; ; Sabater-Lleal M
Hum Mol Genet; 2016 May; 25(9):1867-74. PubMed ID: 26908601
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic analysis of the F11 gene in 14 Turkish patients with factor XI deficiency: identification of novel and recurrent mutations and their inheritance within families.
Colakoglu S; Bayhan T; Tavil B; Keskin EY; Cakir V; Gümrük F; Çetin M; Aytaç S; Berber E
Blood Transfus; 2018 Jan; 16(1):105-113. PubMed ID: 27723456
[TBL] [Abstract][Full Text] [Related]
19. [Identification of compound heterozygous mutations p.Gly400Val and p.Arg532Ter of the F11 gene in a Chinese patient with hereditary factor XI deficiency].
Shu K; Xu K; Li F; Chen T; Liu J; Jin S; Guo J; Zhang Z; Jiang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):522-526. PubMed ID: 30098248
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of a pedigree affected with hereditary coagulation factor XI deficiency due to compound heterozygous variants of F11 gene].
Yang T; Zhu J; Yang Q; Liu J; Yang L; Wang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Mar; 38(3):242-246. PubMed ID: 33751533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
